Ocugen, Inc. (OCGN)

NASDAQ

$0.91

$+0.01

(+0.67%)

Pre-Market

Ocugen, Inc. (OCGN) Live Price Chart

Last updated: ⁦2026-10-14 11:42:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Ocugen, Inc. (OCGN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.91, with a market capitalisation of $321.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.87 to $2.73. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$321.21M
Open	$0.90
Day's High	$18.77
Day's Low	$0.17
Previous Close	$0.89
Volume	201.92K
Average Volume	6.10M
P/E Ratio	--
52-Week High	$2.73
52-Week Low	$0.87
Dividend Yield	--
Earnings Date	--

Ocugen, Inc. (OCGN) Pre-Market Stock Price

Ocugen, Inc. (OCGN) is trading at $0.91 in pre-market trading as of 2026-10-14 11:41:00, up 2.21% ($0.02) from the previous close of $0.89

Pre-market trading shows how investors are pricing OCGN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Ocugen, Inc. (OCGN) 7-Day Stock Price Change

Over the past seven days, Ocugen, Inc. (OCGN) moved from $1.04 to $0.91, representing a decline of 12.98% ($0.14).

The stock traded between $0.87 and $1.12 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 7.36 million shares, up versus the previous seven-day period, indicating higher trading activity.

OCGN 52-Week Price Position

Position in Range: 1.9%

52W Low$0.87

52W High$2.73

OCGN is currently trading at $0.91, placing it 1.9% of the way from its 52-week low of $0.87 to its 52-week high of $2.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ocugen, Inc. (OCGN)?

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	116
Exchange	NASDAQ
Company Website	https://www.ocugen.com

How to Buy Ocugen, Inc. (OCGN) Stock on MEXC

Eligible investors can buy real shares of Ocugen, Inc. (OCGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for OCGN and Place Your Order

Open the RealStocks trading page and search for OCGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ocugen, Inc. (OCGN) stock price today?

Ocugen, Inc. (OCGN) is currently trading at $ 0.91, up 2.21% ($0.02) from the previous close of $ 0.89. Intraday prices update in real time during regular trading hours.

2.Is OCGN stock going up or down today?

As of 2026-10-14 11:41:00, OCGN is trading at $ 0.91, up 2.21% ($0.02) from its previous close of $ 0.89. The stock has traded between $ 0.17 and $ 18.77 during today’s regular session. Past price movements do not guarantee future results.

3.What is OCGN pre-market price?

As of 2026-10-14 11:41:00, OCGN is trading at $ 0.91 in pre-market trading, up 2.21% ($0.02) from the previous close of $ 0.89. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is OCGN after-hours price?

As of 2026-10-14 11:41:00, OCGN is trading at $ 0.90 in after-hours trading, up 1.54% ($0.01) from the regular-session close of $ 0.89. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is OCGN stock trading now?

OCGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does OCGN sit relative to its 52-week high and low?

Over the past 52 weeks, OCGN has traded between a low of $ 0.87 and a high of $ 2.73. At $ 0.91, the stock is positioned 1.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ocugen, Inc. in?

Ocugen, Inc. (OCGN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ocugen, Inc.'s market capitalisation and where is it listed?

Ocugen, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 321.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is OCGN valued in terms of P/E ratio and EPS?

OCGN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ocugen, Inc. pay a dividend?

Ocugen, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.